Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Zhengyun Zou"'
Autor:
Jiujie Cui, Qihan Fu, Xiaobing Chen, Yanling Wang, Qi Li, Feng Wang, Zhihua Li, Guanghai Dai, Yusheng Wang, Hongmei Zhang, Houjie Liang, Jun Zhou, Liu Yang, Fenghua Wang, Leizhen Zheng, Xiaofeng Chen, Ping Gong, Jiang Liu, Ying Yuan, Lin Wang, Yuejuan Cheng, Jun Zhang, Yuhong Zhou, Weijian Guo, Xianbao Zhan, Zhengyun Zou, Da Li, Shan Zeng, Enxiao Li, Zhiwei Li, Zan Teng, Dan Cao, Jie Kan, Jianping Xiong, Ming Quan, Jiayu Yao, Haiyan Yang, Liwei Wang
Publikováno v:
Journal of Pancreatology, Vol 7, Iss 1, Pp 1-9 (2024)
Objective:. Real-world diagnostic and treatment data for pancreatic cancer in China are lacking. As such, the present study investigated the clinical characteristics, diagnosis, and treatment of advanced pancreatic cancer (including locally advanced
Externí odkaz:
https://doaj.org/article/2e0a1c4b680346ddb97288531b46b3bf
Autor:
Lin Li, Rong Huang, Huizi Sha, Baorui Liu, Zhengyun Zou, Guiying Zhang, Yu Ren, Fufeng Wang, Jiayu Wang, Lianjun Zhao, Kelin Zheng, Mengke Zhao, Donglin Kang, Xinyu Su, Yirong Wu, Wangling Zhang, Ruihe Lai, Rui Mei, Yitao Wang, You Tian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Background Previous studies have suggested the potential synergistic antitumor activity when combining immune checkpoint inhibitors with anti-angiogenic agents in various solid tumors. We aimed to assess the efficacy and safety of camrelizumab (a hum
Externí odkaz:
https://doaj.org/article/2ab4f235676b411f89e6c29c72b88c6c
Autor:
Rong Huang, Mengke Zhao, Guiying Zhang, Yueling Yang, Jiayu Wang, Kelin Zheng, Lin Li, Xinyu Su, Lianjun Zhao, Yirong Wu, Zhengyun Zou
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Introduction Acral melanoma (AM) is the most common subtype of malignant melanoma in China, with a very poor prognosis. Despite the frequent reporting of trauma events in AM cases, the precise etiology of AM remains elusive. Methods A retros
Externí odkaz:
https://doaj.org/article/ca97e358e96f4e5895c465859e2aff6e
Autor:
Chuanliang Cui, Yu Chen, Zhiguo Luo, Zhengyun Zou, Yu Jiang, Hongming Pan, Qingxia Fan, Jianfu Zhao, Qing Xu, Renbing Jiang, Xuan Wang, Taiyang Ma, Zhen Guo, Lu Si, Zhihong Chi, Xinan Sheng, Yiwei Dou, Qian Tan, Di Wu, Jun Guo
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Pucotenlimab is a novel recombinant humanized anti-PD-1 (Programmed death-1) monoclonal antibody, which belongs to the human IgG4/kappa subtype, and can selectively block the binding of PD-1 with its ligands PD-L1 and PD-L2. Metho
Externí odkaz:
https://doaj.org/article/83c21142fb064ae8ae697bb5f09ec8bc
Autor:
Rong Huang, Gaigai Shen, Yu Ren, Kelin Zheng, Jiayu Wang, Yan Shi, Jiani C. Yin, Lanqun Qin, Guiying Zhang, Mengke Zhao, Xinyu Su, Luqiao Li, Fufeng Wang, Yang Shao, Baorui Liu, Zhengyun Zou
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Acral melanoma (AM) is the most common subtype in Chinese melanoma patients with a very poor prognosis. However, our understanding of the disease pathogenesis and molecular landscape is limited by the few studies that have been co
Externí odkaz:
https://doaj.org/article/ff00e37ea1e243f0a1268bf269162547
Autor:
Juan Du, Linxi Zhu, Huizi Sha, Zhengyun Zou, Jie Shen, Weiwei Kong, Lianjun Zhao, Qing Gu, Lixia Yu, Yudong Qiu, Baorui Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimWe aimed to evaluate the efficacy and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression in unresectable pancreatic cancer.MethodsThe expression of BRCA1 mRNA in tumor tissues of 25 patients
Externí odkaz:
https://doaj.org/article/438fd0f798fa4b83a211824d8bd195be
Autor:
Yuxin Shu, Nanfei Yang, Nan Cheng, Zhengyun Zou, Wenlong Zhang, Yuncheng Bei, Qian Shi, Menghao Qin, Wei-Guo Zhu, Pingping Shen
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/495f2074ed164518aac864ec1da28f8c
Autor:
Wangshu Dai, Xin Qiu, Changchang Lu, Zhengyun Zou, Huizi Sha, Weiwei Kong, Baorui Liu, Juan Du
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTo date, chemotherapy remains the only effective treatment of unresectable pancreatic adenocarcinoma. In the past few years, the interest in immunological anticancer therapy rises sharply. AGIG is a novel chemo-immunotherapy regimen that co
Externí odkaz:
https://doaj.org/article/f7bf11da14d14981a8a2298692f0e8cc
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
A 48-year old woman was diagnosed with metastatic pancreatic acinar cell carcinoma (PACC) and with a marked elevation in alpha-fetoprotein (AFP), this being a recognized but uncommon feature of PACC. As she refused chemotherapy, the combined therapy
Externí odkaz:
https://doaj.org/article/12ba1a78fe464da88de02c28158562b5
Autor:
Chenxi Liu, Jie Shao, Yanbing Dong, Qiuping Xu, Zhengyun Zou, Fangjun Chen, Jing Yan, Juan Liu, Shuangshuang Li, Baorui Liu, Jie Shen
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Advanced hepatocellular carcinoma (HCC) is a highly lethal disease, mainly due to the late stage at diagnosis and its rapid progression. Although patients with advanced HCC can choose targeted therapy or chemotherapy, overall, the treatment response
Externí odkaz:
https://doaj.org/article/cd901177e4b647aaa516de6e34da30dc